Marshall University
Inhibition of the mTOR signaling pathway in clear cell renal cell carcinoma cells
Abstract
dc:description.abstractThe mammalian target of Rapamycin (mTOR) is a Serine/threonine kinase that is found in two large protein complexes that are known as mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). Torin 1 is an ATP-competitive inhibitor of mTOR that inhibits mTOR activity in both mTORC1 and mTORC2. In this study, we hypothesized that dual inhibition of mTORC1 and mTORC2 with Torin 1 promotes the apoptosis of clear cell renal cell carcinoma cells. The human clear cell renal cell cancer line, 786-0, was treated with Torin 1, and markers of apoptosis, including PARP, Caspase 3, and Caspase 9, and their cleaved subunit proteins were studied using the Western Blot technique. To further investigate the role of mTORC2, short interfering RNA (siRNA) experiments in 786-0 cells were performed to selectively reduce the expression of Rictor, the defining subunit of mTORC2. Our findings demonstrate increased expression of Caspase 3 and Cleaved PARP in 786-0 cells treated with Torin1 which confirms activation of apoptosis. No human or animal was involved in this study.
Degree
thesis:*- Name thesis:degree_name
- Biomedical Sciences
- Level thesis:degree_level
- Thesis
- Discipline thesis:degree_discipline
- Joan C. Edwards School of Medicine
Author and committee
dc:creator, dc:contributor.*- Author dc:creator
-
- Farimand, Samaneh
- Contributors dc:contributor
-
- Dr. Travis Salisbury, Committee Chairperson
- Dr. Richard Egleton
- Dr. Larry Grover
Identifiers
dc:identifier.*- Repository record dc:identifier
- https://mds.marshall.edu/etd/1769